drugset / Trial / NCT01366573

GSK1521498 Alcohol Interaction Study

NCT01366573

Phase 1 Completed 1 enrolled GlaxoSmithKline University of Cambridge · collab
RandomizedCrossoverDouble-blindTreatment

Summary

The aim of the study is to assess the safety and tolerability of GSK1521498 in combination with alcohol and to determine the amount of GSK1521498 and alcohol in your blood after you have been given these together. The study will also determine whether GSK1521498 will have an effect on alcohol liking and consumption.

Timeline

Start
2011-05-13
Primary completion
2011-09-16
Completion
2011-09-16

Drugs

EvaluationDrugModalityDoseRoute
Subject GSK1521498 Small molecule 20 mg

Indications